1 The irreversible inhibitor of p-opioid receptor-mediated effects, P-funaltrexamine (P-FNA), was used to investigate the selectivity of various opioid agonists at gi-opioid receptors in the electrically stimulated guinea-pig ileum and mouse vas deferens preparations in vitro.2 In the guinea-pig ileum, pretreatment with P-FNA (3 x 10-8-3 x 10-6M) produced a concentration-dependent antagonism of the inhibitory effect produced by the pt-opioid receptor agonist [D-Ala2, MePhe4, Gly(ol)5]enkephalin (DAGO). High concentrations of P-FNA (3 x 10-6_ X 10-5M) also antagonized the inhibitory effects of the c-opioid agonist U50488.3 Pretreatment of guinea-pig ileum with P-FNA at I x 10-6M resulted in blockade of the effect of some opioid agonists. The compounds which showed the largest rightward shifts in their concentration-response curves, and hence the greatest i/K opioid receptor selectivity, were nalbuphine, [D-Ser2, Leu5]enkephalinyl-Thr6(DSLET), morphine, DAGO and normophine. Responses to tifluadom, Mr 2034, ethylketocyclazocine, butorphanol, nalorphine, proxorphan and U50488 were not inhibited by P-FNA. 4 In the mouse vas deferens, pre-treatment with P-FNA (I x 10-6M) produced a similar shift in the dose-response curves for normophine as in the guinea-pig ileum. The concentration-response curves for the 6-receptor agonists [D-Ala2, D-Leu'] enkephalin (DADLE) and DSLET were, however, also shifted, indicating that P-FNA will also block 6-opioid receptors. 5 Since P-FNA does not block K-opioid receptor-mediated effects, it can be used in the guinea-pig ileum preparation as a selective is-receptor inhibitor. However, its lack of selectivity between JL-and 6-opioid receptors should be taken into account in many other isolated tissues and experiments in vivo.